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Abstract
Introduction: Preanalytical variables account for most of laboratory errors. There is a wide range of factors that affect the reliability of laboratory 
report. Most convenient sample type for routine laboratory analysis is serum. BD Vacutainer® Rapid Serum Tube (RST) (Becton, Dickinson and Com-
pany, Franklin Lakes, NJ, USA) blood collection tube provides rapid clotting time allowing fast serum separation. Our aim was to evaluate the compa-
rability of routine chemistry parameters in BD Vacutainer® RST blood collection tube in reference with the BD Vacutainer® Serum Separating Tubes II 
Advance Tube (SST) (Becton, Dickinson and Company, Franklin Lakes, NJ, USA).
Materials and methods: Blood specimens were collected from 90 participants for evaluation on its results, clotting time and stability study of six 
routine biochemistry parameters: glucose (Glu), aspartate aminotransferase (AST), alanine aminotransferase (ALT), calcium (Ca), lactate dehidroge-
nase (LD) and potassium (K) measured with Olympus AU2700 analyzer (Beckman Coulter, Tokyo, Japan). The significance of the differences between 
samples was assessed by paired t-test or Wilcoxon Matched-Pairs Rank test after checking for normality.
Results: Clotting process was significantly shorter in the RSTs compared to SSTs (2.49 min vs. 19.47 min, respectively; P < 0.001). There was a sta-
tistically significant difference between the RST and SST II tubes for glucose, calcium and LD (P < 0.001). Differences for glucose and LD were also 
clinically significant. Analyte stability studies showed that all analytes were stable for 24 h at 4 ˚C.
Conclusions: Most results (except LD and glucose) from RST are comparable with those from SST. In addition, RST tube provides shorter clotting 
time.
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Preanalytical variables account for most of labora-
tory errors and there are many factors that affect 
and contribute to the results from a patient (1). 
Quality of a specimen depends of preanalytical 
variables like specimen collection, physiologic and 
endogenous interference factors (1,2). Specimen 
collection variables, such as, duration of fasting, 
time of specimen collection, posture during blood 
sampling, the effects of anticoagulants and stabi-
lizing additives used for blood collection can af-
fect biochemical, hematological and coagulation 
tests results (1,3,4). For some routine biochemical 
laboratory tests, results can be changed by choice 
of blood collection tube and storage conditions 
(3,5,6).
An important component for a laboratory results 
quality is specimen quality and the time required 
to obtain a suitable specimen (serum/plasma) (7). 
Improvement in the turn-around-time (TAT) is very 
important to clinicians (8). Plasma has advantages 
of shorter processing time and reduced centrifu-
gation time, but analyte stability is greater in se-
rum (1,9,10). Serum remains stable for extended 
periods once it has been separated from the clot. 
Differences in results values between plasma and 
serum have been documented (9,10). A shortcom-
ing of serum testing is longer clotting time (9,11). 
Serum tubes should be allowed to clot for mini-
mum 30 minutes to ensure complete clot forma-
tion. Blood from patient who are receiving antico-
agulant therapy may take longer to clot (12,13).
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BD SST II Advance Tube (Becton, Dickinson and 
Company, Franklin Lakes, NJ, USA) requires a mini-
mum clotting time of 30 minutes prior to centrifu-
gation to obtain serum (9). To provide “plasma ad-
vantage”, Becton Dickinson offers the BD RST (Bec-
ton, Dickinson and Company, Franklin Lakes, NJ, 
USA). RST contains a thrombin additive that can 
provide rapid (five minute) clotting time allowing 
rapid serum separation and shorter TAT (9,12,13).
The hypothesis of this study was that there is no 
difference between the tested tubes. The aim was 
to evaluate the comparability of routine chemistry 
parameters: glucose (Glu), aspartate aminotrans-
ferase (AST), alanine aminotransferase (ALT), total 
calcium (Ca), lactate dehidrogenase (LD) and po-
tassium (K) in BD RST and reference BD SST II Ad-
vance serum tubes. Archived samples (at 4 °C) were 
further evaluated for analyte stability by retesting 
for the same analytes after 24 h storage.
Materials and methods
Subjects
The study was conducted between March and 
May 2013 in a Primary care medical biochemistry 
laboratory of Primorsko-goranska county health 
care Rijeka. The total number of samples admitted 
to our laboratory is 600 per day and 20% of all are 
samples from patients on oral anticoagulant ther-
apy (OAT). 90 subjects participated in this study. 
The group consisted of 53 males and 37 females 
with median age of 48 (range 21-71) years. We in-
cluded patients on OAT and healthy controls when 
they had not severe illness or apparent acute in-
flammatory symptoms, and when they had not 
used any prescribed medication. Exclusion criteria 
were history or current cardiovascular, liver or re-
nal disease, diabetes mellitus type 2, malignancies, 
hemolysed and under filled tubes. This study has 
institutional ethics approval with informed con-
sent from all participants.
Study design
Venous blood was collected by routine phleboto-
my by two expert phlebotomists, according to the 
recommendations of the Clinical Laboratory Stand-
ard Institute (CLSI) (14) in the morning between 7-9 
AM in a primary care medical laboratory. Blood 
was collected using a randomized draw order. Ac-
cording to the CLSI document GP34-A (15) it is nec-
essary to alternately sample the control tube and 
the tube to be tested. Sampling was done directly 
into two serum vacuum tubes with clot activator 
and gel separator: Tube I: SST II Advance® 5.0 mL 
(lot, 30802088, Becton, Dickinson and Company 
Franklin Lakes, NJ, USA), Tube II: RST 4.0 mL (lot, 
121212, Becton, Dickinson and Company Franklin 
Lakes, NJ, USA). Tubes were filled to capacity. Both 
tubes were gently inverted to mix the additive/clot 
activator evenly with blood. RST tubes were mixed 
by five complete inversions and SST II Advance 
tubes mixed by six complete inversions immedi-
ately after collection according to the manufactur-
er’s instructions. Tubes were transported from the 
collection room to the laboratory located two floor 
above by a single laboratory technician and left in 
upright position at room temperature (20 °C) to al-
low blood clotting before centrifugation.
Methods
To determine the clotting time, an empirical visual 
review of clot formation was taken for some RST 
and SST tubes (N = 30). Visual observations of clot 
formation were made by single biochemist. Stop 
watch was used to measure the clotting time. Tube 
pairs (RST, SST) were placed side by side in upright 
position with occasional tilting of the tubes to 
check on the clot process. Once a firm clot (when 
approximately 60% of blood clots) was shown, the 
timer was stopped.
After clot formation, all tubes were centrifuged to-
gether at 1500 x g for 10 min at room temperature 
(according to the manufacturer’s instructions) in a 
swing bucket centrifuge. Sera from primary tubes 
were than tested at initial time for six general bio-
chemistry parameters: glucose (Glu), aspartate 
aminotransferase (AST), alanine aminotransferase 
(ALT), total calcium (Ca), lactate dehidrogenase 
(LD) and potassium (K) on the Olympus AU2700 
(Beckman Coulter, Tokyo, Japan) according to the 
manufacturer’s specifications and using original 
Beckman coulter reagents (Beckman Coulter, Brea, 
California, USA). All measurements were performed 
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once. Prior to specimen analysis, we run a two lev-
el quality control (QC) test using manufacturer’s 
controls: control serum level 1 (lot 033) and control 
serum level 2 (lot 034) (Beckman Coulter, Brea, Cal-
ifornia, USA).
After testing, primary tubes were recapped and 
then stored for 24 hours at 4 ˚C. The samples were 
once retested for the same analytes after 24 
hours.
Statistical analyses
The normality of distribution of all variables was 
tested using the Kolmogorov-Smirnov test. Data 
were described by the mean ± standard deviation 
(SD) for normal distribution data and median and 
interquartile range (IQR) for data that did not fol-
low normal distribution. The paired t-test was used 
for parametric data and the Wilcoxon Matched-
Pairs Rank test for non-parametric data to test for 
statistical differences between analytes measured 
from the different tubes. Results were analyzed us-
ing Passing-Bablok and Bland-Altman plots for as-
sociation and differences. Level of significance for 
all statistical comparisons was set as P < 0.05. The 
biases from tubes were compared with the current 
desirable allowable bias based on biological varia-
tion (16) according to the formula B < 0.25 (CVw2 + 
CVg2)1/2 where the CVw is within-subject biologi-
cal variation and CVg is the between-subject bio-
logical variation (17). The biases for each tube were 
calculated according to the formula: mean differ-
ence (%) = [(test tube mean-reference tube mean/
reference tube mean) x 100]. The arithmetic mean 
of these results represents mean difference. Statis-
tical analyses were performed using MedCalc 
12.7.0.0. statistical software (MedCalc Software, 
Mariakerke, Belgium).
Results
As shown in table 1, clotting process was signifi-
cantly shorter in the RSTs compared to SSTs (P < 
0.001). In the RSTs, blood of all participants clotted 
within 9 minutes, while in the SSTs clotted within 
51 minutes.
The summary statistics results for evaluation of 
tested RST against reference SST II Advance tubes 
for six routine chemistry tests results at initial time 
are shown in table 2. Parallel mean tests results for 
AST, ALT and potassium for RSTs were in close 
agreement with that of the reference (SST) tube. 
There was a statistically significant difference (P < 
0.001) between the tubes for glucose, calcium and 
LD. Difference for glucose and LD was also clinical-
ly significant compared with the current desirable 
allowable bias based on biological variation. Bland-
Altman difference plots (Figure 1) showed high 
mean bias for glucose and LD. Glucose was 3.8% 
higher in RST tubes than the mean in reference 
SST II tubes. LD was 5.7 % lower in RST tubes than 
the mean in reference SST II tubes. Passing-Bablok 
regression analysis (Figure 2.) showed that for most 
analytes bias doesn’t exist. However, a constant 
bias was observed for LD (y= -9.00 (-13.8 to -3.0) + 
1.00 (0.96 to 1.02).
Tables 3 and 4 summarize stability studies results. 
Analyte stability studies showed that in RST tube 
there was no statistically significant difference for 
glucose, AST and ALT. Statistically significant differ-
ence was observed for calcium (P = 0.006), potas-
sium (P < 0.001) and LD (P < 0.001). However, these 
differences were not clinically significant; Bland-
Altman means bias showed low within-tube mean 
bias (data not shown). While most of the analytes 
in SST displayed statistically significant difference 
(glucose (P = 0.002), AST (P < 0.001), Ca (P < 0.001) 
Table 1. Comparison of clotting time between RST and SST tubes.
Patients Unit RST SST Mean difference (%) P*
N = 30 min 2.49 (2.05-3.45) 19.47 (15.20-127.45) 86 <0 .001
*P value represents the significance by Wilcoxon Matched-Pairs Rank test. Data are presented as median and interquartile 
range. RST - rapid serum tube; SST – serum separator tube.
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Table 2. Comparison of biochemical parameters between RST and SST tubes.
Parameter (units) RST(N=90) SST II (N=90) Mean bias (%) Desirable bias (%) P
Glu (mmol/L) 5.7 (5.4-6.1) 5.5 (5.1-6.0) 3.9 2.2 < 0 .001*
AST (U/L) 20 ± 6 20 ± 6 0.7 7 0.413
ALT (U/L) 21 ±9 21 ± 9 -0.4 11 0.435
Ca (mmol/L) 2.45 ± 0.09 2.47 ± 0.08 -0.8 0.8 < 0 .001
LD (U/L) 180 ± 42 189 ± 40 -5.3 4 < 0 .001
K (mmol/L) 4.5 ± 0.4 4.5 ± 0.4 0.4 1.8 0.406
Data are presented as mean ± SD or median (interquartile range). Level of significance was tested using paired t-test 
(*Wilcoxon Matched-Pairs Rank test). RST - rapid serum tube; SST – serum separator tube; Glu - glucose, AST - aspartate 
aminotransferase, ALT - alanine aminotransferase, Ca -total calcium, LD - lactate dehidrogenase, K – potassium.
Table 3. Stability of biochemistry analytes in RST tubes (N = 90) after 24 h storage at 4oC.
Parameter (units) RST (t0) RST (t24) Mean bias (%)
Desirable bias 
(%) P
Glu (mmol/L) 5.7 (5.4-6.1) 5.7 (5.4-6.1) 0.05 1.5 0.514*
AST (U/L) 20 ± 6 21 ± 6 -0.7 2 0.079
ALT (U/L) 21 ±9 21 ±9 -0.8 3 0.303
Ca (mmol/L) 2.45 ± 0.09 2.46 ± 0.1 -0.5 0.8 0.006
LD (U/L) 180 ± 42 178 ± 41 1.3 2 < 0.001
K (mmol/L) 4.5 ± 0.4 4.5 ± 0.4 -0.9 1.5 < 0.001
Data are presented as mean ± SD or median (interquartile range). Level of significance was tested using paired t-test 
(*Wilcoxon Matched-Pairs Rank test). RST (t0) – initial concentration in the rapid serum tube; RST (t24) – concentration after 
24 hours in the rapid serum tube; Glu - glucose, AST - aspartate aminotransferase, ALT - alanine aminotransferase, Ca -total 
calcium, LD - lactate dehidrogenase, K – potassium.
Table 4. Stability of biochemistry analytes SST tubes (N = 90) after 24 h storage at 4oC.





Glu (mmol/L) 5.5 (5.1-6.0) 5.5 (5.1-6.0) -0.5 1.5 0.002*
AST (U/L) 20 ± 6 21 ± 6 -0.7 2 < 0.001
ALT (U/L) 21 ± 9 21± 9 -0.8 3 0.463
Ca (mmol/L) 2.47 ± 0.08 2.49 ± 0.1 -0.5 0.8 < 0.001
LD (U/L) 189 ± 40 188 ± 36 1.3 2 0.190
K (mmol/L) 4.5 ± 0.4 4.5 ± 0.4 -1.1 1.5 < 0.001
Data are presented as mean ± SD or median (interquartile range). Level of significance was tested using paired t-test 
(*Wilcoxon Matched-Pairs Rank test). SST II (t0) – initial concentration in the serum separator tube; SST II (t24) – concentration 
after 24 hours in the serum separator tube; Glu - glucose, AST - aspartate aminotransferase, ALT - alanine aminotransferase, 
Ca -total calcium, LD - lactate dehidrogenase, K – potassium.
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Glucose difference plot Aspartate aminotransferase difference plot
Alanine aminotransferase difference plot Calcium difference plot
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Legend:
Figure 1. Bland-Altman difference plot between RST and SST tubes for: (a) glucose, (b) aspartate aminotransferase, (c) alanine amin-
otransferase, (d) calcium, (e) lactate dehidrogenase, (f) potassium.
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Figure 2. Passing-Bablok regression analysis.
Results comparison between RST and SST tubes for: (a) glucose, (b) aspartate aminotransferase, (c) alanine aminotransferase, (d) cal-
cium, (e) lactate dehidrogenase, (f) potassium.
Glucose scatter plot with Passing and Bablok fit AST scatter plot with Passing and Bablok fit
ALT scatter plot with Passing and Bablok fit










y = 0.23 (–0.004 to 0.4) + 1.00 (0.96 to 1.04) x
y = –9.00 (–13.8 to –3.0) + 1.00 (0.96 to 1.02) x
y = –0.02 (–0.26 to 0.02) + 1.00 (1.00 to 1.00) x
y = 0 (–0.51 to 0) + 1.00 (1.00 to 1.10) x
y = 0 (0 to 0) + 1.00 (1.00 to 1.00) x
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and potassium (P < 0.001)), none of them displayed 
clinical significance.
Discussion
This study evaluated the BD RST tube in a primary 
care medical laboratory for six routine chemistry 
analytes. We found that use of this tube represents 
an improvement over the current SST serum tube 
for certain parameters. The main findings are: (i) 
clotting time is significantly shorter in the RSTs 
compared to SSTs; (ii) significant statistical and 
clinical difference between the RST tubes related 
to the SST II tubes for glucose and LD; (iii) all ana-
lytes are stable for 24 h storage.
RST provides rapid clotting time allowing rapid se-
rum separation. Visible clotting was achieved rap-
idly in RST specimens; especially in healthy sub-
jects. Patients receiving anticoagulants have a lit-
tle longer clotting time ~10 min. According to 
Dimeski et al. (12) patients on high dose heparin 
have prolonged clotting time in RST up to 20 min 
or longer.
Similarities and differences in the concentration of 
tested analytes measured in RST have been re-
ported previously (7,12,18). In the study of Ng and 
Yeo (7), no differences in the concentrations of test 
analytes were observed, while study Dimeski et al. 
(12) shows the difference in LD activity. They at-
tributed this difference to a faster clotting process 
which minimizes cell lysis. Also, Huyghe et al. (18) 
observed that measured serum LD activity was 
significantly lower among specimens collected in 
RST than those collected in SST II. As the study of 
Parenmark and Landberg (19) showed that mixing 
tubes immediately after venipuncture can increase 
hemolysis index and that mixing blood samples 
after venipuncture is not mandatory for all types 
of tubes (19,20), all hemolysed samples were ex-
cluded from our study in order to prevent the in-
fluence of hemolysis, although inverting the tubes 
versus non inverting did not significantly affect LD 
activity (18). Since incomplete tube filling can af-
fect results tests (significantly higher measured 
potassium concentration and LD activity) (18), all 
incompletely filled samples were also excluded.
Differences for glucose in RST have not been re-
ported previously. The possible explanation for 
higher glucose concentration in the RST tube com-
pared with the SST tube is due to faster clotting, 
which affects the metabolism of serum glucose in 
collection tubes. Although according to data from 
Fernandez et al. (21) and Li et al. (22) serum separa-
tor tubes or tubes with a fluoride glycolysis inhibi-
tor may be used for glucose determinations with 
no difference in reported results.
Analyte stability on serum storage at 4 °C showed 
no significant difference after 24 h. These findings 
are similar with results of study Ng and Yeo (7).
The main limitations of this study were the small 
number of patients and not standardized clotting 
time measurement.
Our conclusion is that data (except for LD and glu-
cose) obtained in study are comparable between 
RSTs and SSTs. In addition, RST provides shorter 
clotting time.
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